Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2023-09-11 Share Issue/Capital Cha…
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Nghị quyết HĐQT về việc sửa đổi điều lệ, đăng ký chứng khoán bổ sung tại VSD và NYCP bổ sung trên sàn HOSE
Share Issue/Capital Change Classification · 96% confidence The text is a corporate board resolution (Nghị quyết HĐQT) approving an increase of charter capital by issuing additional shares, amending the company’s charter, registering the new shares with the central securities depository and listing them on HOSE. This is an announcement of a share issuance/capital change. According to the definitions, this falls under 'Share Issue/Capital Change' (Code: SHA).
2023-09-11 Vietnamese
DBT: Giấy xác nhận thay đổi nội dung đăng ký doanh nghiệp (thay đổi ngành nghề kinh doanh)
Regulatory Filings Classification · 90% confidence The document is an ‘‘extraordinary information disclosure’’ by a Vietnamese listed company (Bepharco) to the State Securities Commission and stock exchange, detailing a corporate change in its registered business activities following confirmation by the business registration office. It is not a financial report, earnings release, proxy, or other specified category but rather a general regulatory announcement of a corporate change. Thus it falls under Regulatory Filings (RNS).
2023-08-30 Vietnamese
DBT: Nghị quyết HĐQT về việc vay vốn tại Ngân hàng Ngoại thương VN
Capital/Financing Update Classification · 87% confidence The document is a regulatory disclosure by Bến Tre Pharma (DBT) reporting the Board of Directors’ resolution to borrow VND 20 billion from Vietcombank. It is not an Annual Report, Audit Report, or management change notice. Instead, it details a financing arrangement (loan amount, purpose, security, terms), fitting the “Capital/Financing Update” category.
2023-08-29 Vietnamese
DBT: Đính chính nội dung Nghị quyết HĐQT số 51/130423/NQ-DBT
Regulatory Filings Classification · 80% confidence The document is a formal disclosure (“Thông tin công bố”) to the State Securities Commission and HSX correcting a prior Board of Directors’ resolution. It contains the full text of a Board resolution amendment but does not report financial results, management appointments, dividend notices, or share transactions. It is a general regulatory announcement/correction filing, fitting the fallback “Regulatory Filings (RNS)” category.
2023-08-24 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua kết quả phát hành cổ phiếu ESOP
Share Issue/Capital Change Classification · 92% confidence The document is a formal corporate disclosure to the Vietnam SEC and HOSE from the Board of Directors of Bepharco approving the results of employees exercising their rights to purchase shares under the ESOP program. It details the number of new shares issued and lists the recipients. This is an announcement of a new share issuance/capital change event, fitting the Share Issue/Capital Change category (SHA).
2023-08-22 Vietnamese
DBT: Báo cáo kết quả phát hành cổ phiếu theo chương trình lựa chọn cho người lao động
Share Issue/Capital Change Classification · 95% confidence The document is a formal disclosure to the securities regulator and exchange, detailing the issuance of 700,000 new ordinary shares under an employee stock option program (ESOP), including pre- and post-issuance share counts, subscription price, timetable, and supporting resolutions. This constitutes a capital change via a share issue rather than an annual or interim financial report, management discussion, or dividend notice. Therefore, it falls squarely under the Share Issue/Capital Change category (Code: SHA).
2023-08-22 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.